Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnesium | 5 | 2018 | 813 | 2.000 |
Why?
|
Proton Pump Inhibitors | 5 | 2016 | 521 | 1.790 |
Why?
|
Magnesium Deficiency | 3 | 2018 | 47 | 1.640 |
Why?
|
Critical Illness | 10 | 2020 | 2665 | 1.640 |
Why?
|
Acute Kidney Injury | 7 | 2020 | 1967 | 1.520 |
Why?
|
Lead | 4 | 2023 | 854 | 1.440 |
Why?
|
Kidney Failure, Chronic | 8 | 2022 | 2536 | 1.400 |
Why?
|
Acidosis, Lactic | 2 | 2020 | 142 | 1.090 |
Why?
|
Water-Electrolyte Balance | 3 | 2015 | 346 | 1.010 |
Why?
|
Water-Electrolyte Imbalance | 2 | 2016 | 113 | 1.000 |
Why?
|
Vitamin K | 3 | 2016 | 294 | 0.850 |
Why?
|
Kidney | 6 | 2023 | 7167 | 0.830 |
Why?
|
Protein Precursors | 2 | 2016 | 1154 | 0.820 |
Why?
|
Edema | 2 | 2016 | 790 | 0.810 |
Why?
|
Fluorides | 1 | 2022 | 126 | 0.810 |
Why?
|
Renal Dialysis | 4 | 2022 | 1780 | 0.780 |
Why?
|
Metals, Heavy | 1 | 2022 | 139 | 0.760 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2022 | 2195 | 0.710 |
Why?
|
Central Venous Pressure | 2 | 2016 | 78 | 0.700 |
Why?
|
Anaplasmosis | 1 | 2019 | 36 | 0.680 |
Why?
|
Calcinosis | 3 | 2016 | 1497 | 0.670 |
Why?
|
Hematinics | 1 | 2021 | 281 | 0.640 |
Why?
|
Resuscitation Orders | 1 | 2020 | 267 | 0.640 |
Why?
|
Kidney Diseases | 3 | 2023 | 2145 | 0.620 |
Why?
|
Alanine | 1 | 2020 | 572 | 0.620 |
Why?
|
Critical Care | 2 | 2020 | 2640 | 0.600 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2020 | 615 | 0.570 |
Why?
|
Histamine H2 Antagonists | 2 | 2015 | 165 | 0.570 |
Why?
|
Hypovolemia | 1 | 2016 | 45 | 0.570 |
Why?
|
Homeostasis | 3 | 2018 | 3335 | 0.550 |
Why?
|
Hemoglobins | 1 | 2021 | 1532 | 0.520 |
Why?
|
Kidney Medulla | 1 | 2014 | 182 | 0.480 |
Why?
|
Hydroxycholecalciferols | 1 | 2013 | 44 | 0.470 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2015 | 135 | 0.470 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 96 | 0.470 |
Why?
|
Warfarin | 3 | 2015 | 1493 | 0.450 |
Why?
|
Intensive Care Units | 6 | 2016 | 3679 | 0.450 |
Why?
|
Influenza Vaccines | 1 | 2020 | 733 | 0.440 |
Why?
|
Minority Groups | 1 | 2020 | 1215 | 0.420 |
Why?
|
Diuretics | 4 | 2016 | 591 | 0.400 |
Why?
|
Metabolic Diseases | 1 | 2018 | 657 | 0.390 |
Why?
|
Patient Admission | 2 | 2016 | 1380 | 0.390 |
Why?
|
Vascular Diseases | 2 | 2010 | 1155 | 0.380 |
Why?
|
Sodium | 1 | 2016 | 1627 | 0.380 |
Why?
|
Atherosclerosis | 2 | 2016 | 3428 | 0.360 |
Why?
|
Glucocorticoids | 1 | 2019 | 2107 | 0.350 |
Why?
|
Insulin Resistance | 2 | 2013 | 3861 | 0.340 |
Why?
|
Anticoagulants | 4 | 2015 | 4595 | 0.330 |
Why?
|
Calcium-Binding Proteins | 2 | 2016 | 1081 | 0.320 |
Why?
|
Vaccination | 1 | 2020 | 3256 | 0.320 |
Why?
|
Water | 1 | 2014 | 1388 | 0.310 |
Why?
|
Hospitals | 2 | 2020 | 3937 | 0.290 |
Why?
|
Aged | 20 | 2021 | 162944 | 0.290 |
Why?
|
Nutrition Surveys | 3 | 2022 | 1656 | 0.280 |
Why?
|
Middle Aged | 23 | 2021 | 213127 | 0.280 |
Why?
|
Prothrombin | 2 | 2016 | 185 | 0.270 |
Why?
|
Obesity | 4 | 2016 | 12705 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 2145 | 0.260 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3151 | 0.250 |
Why?
|
Arrhythmias, Cardiac | 1 | 2015 | 2267 | 0.250 |
Why?
|
Aged, 80 and over | 10 | 2020 | 57683 | 0.250 |
Why?
|
Hospital Mortality | 4 | 2020 | 5310 | 0.240 |
Why?
|
Albuminuria | 1 | 2008 | 683 | 0.240 |
Why?
|
Humans | 40 | 2023 | 742088 | 0.230 |
Why?
|
Extracellular Matrix Proteins | 1 | 2008 | 849 | 0.230 |
Why?
|
Fluoridation | 1 | 2022 | 29 | 0.220 |
Why?
|
United States | 10 | 2022 | 69693 | 0.210 |
Why?
|
Risk Factors | 13 | 2020 | 72145 | 0.210 |
Why?
|
Male | 23 | 2021 | 349538 | 0.200 |
Why?
|
Contrast Media | 1 | 2015 | 5295 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 24913 | 0.200 |
Why?
|
United States Environmental Protection Agency | 1 | 2021 | 139 | 0.190 |
Why?
|
Cadmium | 1 | 2022 | 212 | 0.190 |
Why?
|
Female | 23 | 2021 | 379592 | 0.190 |
Why?
|
Oliguria | 1 | 2020 | 21 | 0.190 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1675 | 0.190 |
Why?
|
Blood Pressure | 2 | 2013 | 8541 | 0.180 |
Why?
|
Sodium Bicarbonate | 1 | 2020 | 62 | 0.180 |
Why?
|
Water Supply | 1 | 2021 | 214 | 0.180 |
Why?
|
Medical Record Linkage | 1 | 2021 | 284 | 0.180 |
Why?
|
Minority Health | 1 | 2020 | 86 | 0.170 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.170 |
Why?
|
Prognosis | 5 | 2020 | 29010 | 0.170 |
Why?
|
Anaplasma phagocytophilum | 1 | 2019 | 37 | 0.170 |
Why?
|
Vitamin D | 1 | 2012 | 3211 | 0.160 |
Why?
|
Databases, Factual | 3 | 2021 | 7716 | 0.160 |
Why?
|
Bone and Bones | 1 | 2008 | 2575 | 0.150 |
Why?
|
Erythropoiesis | 1 | 2021 | 705 | 0.150 |
Why?
|
Juxtaglomerular Apparatus | 1 | 2016 | 15 | 0.150 |
Why?
|
Body Fluid Compartments | 1 | 2016 | 52 | 0.140 |
Why?
|
Pressoreceptors | 1 | 2016 | 100 | 0.140 |
Why?
|
Vitamin K Deficiency | 1 | 2016 | 24 | 0.140 |
Why?
|
Down-Regulation | 2 | 2014 | 3001 | 0.140 |
Why?
|
Ankle Brachial Index | 1 | 2016 | 154 | 0.140 |
Why?
|
Comorbidity | 3 | 2016 | 10372 | 0.130 |
Why?
|
Logistic Models | 3 | 2016 | 13403 | 0.130 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4246 | 0.130 |
Why?
|
Triiodobenzoic Acids | 1 | 2015 | 123 | 0.130 |
Why?
|
Nephrons | 1 | 2016 | 220 | 0.130 |
Why?
|
Blood Volume | 1 | 2016 | 565 | 0.130 |
Why?
|
Thirst | 1 | 2014 | 38 | 0.120 |
Why?
|
Intestinal Absorption | 1 | 2015 | 420 | 0.120 |
Why?
|
Seasons | 1 | 2020 | 1492 | 0.120 |
Why?
|
Sepsis | 2 | 2020 | 2589 | 0.120 |
Why?
|
Osmotic Pressure | 1 | 2014 | 151 | 0.120 |
Why?
|
Drug Dosage Calculations | 1 | 2014 | 113 | 0.120 |
Why?
|
Cardiac Output | 1 | 2016 | 853 | 0.120 |
Why?
|
Diabetes Insipidus | 1 | 2014 | 151 | 0.120 |
Why?
|
Kidney Tubules, Collecting | 1 | 2014 | 178 | 0.120 |
Why?
|
Calciphylaxis | 1 | 2015 | 122 | 0.120 |
Why?
|
Neprilysin | 1 | 2016 | 439 | 0.120 |
Why?
|
Vascular Resistance | 1 | 2016 | 936 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9963 | 0.110 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 535 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2016 | 415 | 0.110 |
Why?
|
Vasopressins | 1 | 2014 | 370 | 0.110 |
Why?
|
Body Mass Index | 3 | 2016 | 12695 | 0.110 |
Why?
|
Cell Size | 1 | 2014 | 643 | 0.110 |
Why?
|
Cohort Studies | 4 | 2016 | 40450 | 0.110 |
Why?
|
Fluid Therapy | 1 | 2016 | 592 | 0.100 |
Why?
|
Risk Assessment | 4 | 2016 | 23320 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15530 | 0.100 |
Why?
|
Adult | 8 | 2022 | 213712 | 0.100 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 759 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2020 | 77098 | 0.100 |
Why?
|
Hyponatremia | 1 | 2014 | 298 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1179 | 0.100 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 578 | 0.100 |
Why?
|
Boston | 2 | 2014 | 9305 | 0.090 |
Why?
|
Vitamin D Deficiency | 2 | 2012 | 1331 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 113 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12344 | 0.090 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 923 | 0.090 |
Why?
|
Polypharmacy | 1 | 2013 | 294 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2013 | 643 | 0.090 |
Why?
|
Serum Albumin | 1 | 2013 | 674 | 0.090 |
Why?
|
Sensory Receptor Cells | 1 | 2014 | 487 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1517 | 0.090 |
Why?
|
Creatinine | 1 | 2015 | 1916 | 0.090 |
Why?
|
Phosphates | 1 | 2013 | 786 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15056 | 0.080 |
Why?
|
Heart Failure | 3 | 2020 | 10856 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6483 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1350 | 0.080 |
Why?
|
Tunica Intima | 1 | 2010 | 464 | 0.080 |
Why?
|
Aorta | 1 | 2016 | 2057 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1737 | 0.080 |
Why?
|
Insulin | 2 | 2013 | 6575 | 0.080 |
Why?
|
Hospitalization | 2 | 2020 | 10232 | 0.080 |
Why?
|
Mitral Valve | 1 | 2016 | 1484 | 0.080 |
Why?
|
Brain | 1 | 2014 | 26343 | 0.080 |
Why?
|
Incidence | 2 | 2016 | 20928 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.070 |
Why?
|
Phosphorus | 1 | 2008 | 338 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15108 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.070 |
Why?
|
Calcitriol | 1 | 2008 | 298 | 0.070 |
Why?
|
Aortic Valve | 1 | 2016 | 1911 | 0.070 |
Why?
|
Fasting | 1 | 2012 | 1589 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2010 | 1849 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2059 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6534 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2016 | 3099 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 859 | 0.060 |
Why?
|
Adiposity | 1 | 2013 | 1806 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2366 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8662 | 0.060 |
Why?
|
Curriculum | 1 | 2016 | 3589 | 0.060 |
Why?
|
Body Composition | 1 | 2012 | 2400 | 0.050 |
Why?
|
Morbidity | 1 | 2008 | 1767 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9679 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5948 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Blood Vessels | 1 | 2008 | 1124 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Fibroblast Growth Factors | 1 | 2008 | 879 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6440 | 0.050 |
Why?
|
Parathyroid Hormone | 1 | 2008 | 1801 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7153 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2167 | 0.050 |
Why?
|
Prospective Studies | 2 | 2016 | 53187 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1989 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7901 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15194 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2013 | 13921 | 0.040 |
Why?
|
Exercise | 1 | 2013 | 5611 | 0.040 |
Why?
|
Adolescent | 2 | 2022 | 85649 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11695 | 0.030 |
Why?
|
Young Adult | 1 | 2022 | 56350 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 683 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40054 | 0.030 |
Why?
|
Child | 1 | 2022 | 77478 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16678 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2014 | 206 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10578 | 0.030 |
Why?
|
Chronic Disease | 1 | 2008 | 9144 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2010 | 5019 | 0.030 |
Why?
|
Animals | 2 | 2015 | 168561 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20086 | 0.020 |
Why?
|
Amino Acids | 1 | 2013 | 1727 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62966 | 0.020 |
Why?
|
Body Weight | 1 | 2014 | 4664 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13256 | 0.010 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_